Page last updated: 2024-11-02

pioglitazone and Aortitis

pioglitazone has been researched along with Aortitis in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Aortitis: Inflammation of the wall of the AORTA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Motoki, T1
Kurobe, H1
Hirata, Y1
Nakayama, T1
Kinoshita, H1
Rocco, KA1
Sogabe, H1
Hori, T1
Sata, M1
Kitagawa, T1

Other Studies

1 other study available for pioglitazone and Aortitis

ArticleYear
PPAR-γ agonist attenuates inflammation in aortic aneurysm patients.
    General thoracic and cardiovascular surgery, 2015, Volume: 63, Issue:10

    Topics: Aged; Aortic Aneurysm; Aortitis; Female; Humans; Hypoglycemic Agents; Male; Pioglitazone; PPAR gamma

2015